サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1235848

NGSサンプル調製の世界市場：製品別・ワークフロー別・サンプルの種類別・用途別・手法別・エンドユーザー別・地域別の将来予測 (2028年まで)

NGS Sample Preparation Market by Product, Workflow, Sample Type, Application, Method, End User & Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 289 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
NGSサンプル調製の世界市場：製品別・ワークフロー別・サンプルの種類別・用途別・手法別・エンドユーザー別・地域別の将来予測 (2028年まで)
出版日: 2023年03月06日
発行: MarketsandMarkets
ページ情報: 英文 289 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のNGSサンプル調製の市場規模は、2022年の19億米ドルから、2028年には40億米ドルに達すると予測され、予測期間中のCAGRは13.4%に達する見通しです。

市場成長の主な促進要因として、継続的な技術革新や、高度なNGSシステムを低コストで利用できるようになったことなどが挙げられます。他方、代替技術の存在により、市場の成長はある程度抑制されると予想されます。

用途別では、2022年に疾患診断が最大のシェアを占めています。NGSベース検査に対する有利な償還シナリオや、がん・NIPT向けのNGSベースの製品/サービスの開発に主要企業が注力するようになっていることが、この分野の成長を促進する主な要因となっています。

エンドユーザー別では、教育機関・研究センターが2022年時点で最大のシェアを占めています。その要因として、各地でゲノミクス研究開発向け財政支援が支給されていること、研究者向けに費用対効果の高いNGS製品・サービスが開発されたことなどが挙げられます。

地域別に見ると、北米市場が最大のシェアを占める一方、アジア太平洋が予測期間中に最も高いCAGRで成長する見通しです。

当レポートでは、世界のNGS (次世代シーケンシング) サンプル調製の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、製品/サービス別・ワークフロー別・サンプルの種類別・用途別・手法別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術分析
  • 顧客のビジネスに影響を与える動向/混乱
  • サプライチェーンとバリューチェーンの分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制分析
  • 価格分析
  • 特許分析
  • 主な会議とイベント (2023年)
  • 主な利害関係者と購入基準

第6章 NGSサンプル調製市場：製品/サービス別

  • イントロダクション
  • ワークステーション/機器
  • 試薬・消耗品
  • サービス

第7章 NGSサンプル調製市場：ワークフロー別

  • イントロダクション
  • DNAの断片化とライブラリーの調製
  • ターゲットエンリッチメント
  • 品質管理

第8章 NGSサンプル調製市場：サンプルの種類別

  • イントロダクション
  • DNA
  • RNA

第9章 NGSサンプル調製市場：用途別

  • イントロダクション
  • 疾患診断
    • がん診断
    • リプロダクティブヘルス診断
    • 感染症診断
    • その他の疾患診断用途
  • 創薬
  • 農業・動物研究
  • その他の用途

第10章 NGSサンプル調製市場：手法別

  • イントロダクション
  • 手動サンプル調製
  • マイクロ流体サンプル調製
  • 自動液体ハンドリングベースサンプル調製

第11章 NGSサンプル調製市場：エンドユーザー別

  • イントロダクション
  • 病院・クリニック
  • 教育機関・研究センター
  • 製薬企業・バイオテクノロジー企業
  • その他のエンドユーザー

第12章 NGSサンプル調製市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • 他のアジア太平洋諸国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • 他のラテンアメリカ諸国
  • 中東・アフリカ

第13章 競合情勢

  • イントロダクション
  • 市場関係者が採用する主要な戦略
  • 収益シェア分析 (上位5社)
  • 市場シェア分析 (2022年)
  • 企業評価クアドラント
  • 企業評価クアドラント：スタートアップ/中小企業向け
  • 競合ベンチマーキング
  • 競合シナリオと動向
    • 主な資本取引
    • 主な製品の発売
    • 主な拡張

第14章 企業プロファイル

  • 主要企業
    • ILLUMINA, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • F. HOFFMANN-LA ROCHE LTD.
    • PERKINELMER INC.
    • AGILENT TECHNOLOGIES, INC.
    • DANAHER
    • BECTON, DICKINSON AND COMPANY
    • QIAGEN
    • MERCK KGAA
    • BIO-RAD LABORATORIES, INC.
    • PROMEGA CORPORATION
    • EUROFINS SCIENTIFIC
    • BGI
    • 10X GENOMICS
    • SYSMEX CORPORATION
  • その他の企業
    • PSOMAGEN
    • ZYMO RESEARCH CORPORATION
    • TAKARA BIO INC.
    • NOVOGENE CO., LTD.
    • NEW ENGLAND BIOLABS
    • TECAN TRADING AG
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • PACBIO
    • MEDGENOME
    • SWIFT BIOSCIENCES INC.

第15章 ディスカッションガイド

目次
Product Code: BT 7081

The NGS sample preparation market is projected to reach USD 4.0 billion by 2028 from USD 1.9 billion in 2022, at a CAGR of 13.4% during the forecast period. The key factors driving the growth of the NGS sample preparation market are constant innovations in NGS platforms, and increased availability of advanced NGS systems at low costs. However, the presence of alternative technologies is expected to restrain market growth to a certain extent.

The NGS sample preparation market has been segmented based on products & services, workflow, sample type, method, application, end user, and region.

"By application, the disease diagnostics accounted for the largest share of the NGS sample preparation market"

Based on application, the NGS sample preparation market is categorized into disease diagnostics, drug discovery, agricultural & animal research, and others. The disease diagnostics segment dominated the market in 2022, owing to favorable reimbursement scenario for NGS-based tests and increasing focus of key players on developing NGS-based products & services for cancer and NIPT are the key factors driving the growth of the segment.

"By end user, the academic institutes & research centers accounted for the largest share in the NGS Sample Preparation market"

Based on end user, the NGS sample preparation market is segmented into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. In 2022, the academic institutes & research centers segment accounted for a larger share of the NGS sample preparation market. Growth in this market segment can be attributed to availability of financial support for genomics R&D across regions, and the development of cost-effective NGS products & services for researchers.

"North America: the largest share of the NGS sample preparation market"

North America accounted for the largest share of the NGS sample preparation market. Favorable initiatives by government and private bodies for the adoption of NGS technologies, advancements in NGS sample preparation products, the growing prevalence of target diseases, an increasing number of NGS-based research & clinical applications, growing research on cancer, the rising awareness of NGS services, and the presence of leading NGS service providers, such as Illumina (US), Thermo Fisher Scientific (US), and Agilent Technologies (US), are driving the growth of the NGS sample preparation market in North America.

"Asia Pacific: The fastest-growing region in the NGS sample preparation market."

The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to significant focus on R&D activities as a means of broadening the scope of NGS applications, the increasing adoption of NGS for diagnostics due to the decreasing cost of NGS products and services, and technological development in NGS data analysis. In addition, a number of domestic and international market players focus on strengthening their presence in the Asia Pacific NGS market, while domestic players expand their international reach through partnerships, collaborations, agreements, and expansions.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
  • By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%

Prominent Players

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • PerkinElmer Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (US)
  • Danaher (US)
  • Becton, Dickinson and Company (US)
  • Merck KGAA (Germany)
  • QIAGEN (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • Promega Corporation (US)
  • Eurofins Scientific (Luxembourg)
  • BGI (China)
  • 10x Genomics (US)
  • Sysmex Corporation (US)
  • Psomagen (US)
  • Zymo Research Corporation (US)
  • Takara Bio Inc. (Japan)
  • Novogene Co., Ltd. (China)
  • New England Biolabs (US)
  • Tecan Trading AG (US)
  • Oxford Nanopore Technologies PLC (UK)
  • PacBio (US)
  • Medgenome (US)
  • Swift Biosciences Inc. (US)

Research Coverage:

This report provides a detailed picture of the NGS sample preparation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & services, workflow, sample type, method, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS sample preparation market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 RESEARCH LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS), 2021
    • FIGURE 4 NGS SAMPLE PREPARATION MARKET SIZE (USD MILLION)
    • FIGURE 5 NGS SAMPLE PREPARATION MARKET: FINAL CAGR PROJECTIONS (2023-2028)
    • FIGURE 6 NGS SAMPLE PREPARATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 INDUSTRY INSIGHTS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 GLOBAL RECESSION IMPACT: NGS SAMPLE PREPARATION MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 8 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2028 (USD MILLION)
    • FIGURE 9 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2022 VS. 2028 (USD MILLION)
    • FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2022 VS. 2028 (USD MILLION)
    • FIGURE 11 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2022 VS. 2028 (USD MILLION)
    • FIGURE 12 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION)
    • FIGURE 13 NGS SAMPLE PREPARATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NGS SAMPLE PREPARATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 NGS SAMPLE PREPARATION MARKET OVERVIEW
    • FIGURE 15 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE GROWTH
  • 4.2 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
    • FIGURE 16 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028
    • FIGURE 17 DISEASE DIAGNOSTICS SEGMENT TO DOMINATE MARKET IN 2028
  • 4.4 NGS SAMPLE PREPARATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 NGS SAMPLE PREPARATION MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Constant innovations in NGS platforms
      • 5.2.1.2 Increased availability of advanced NGS systems at low costs
    • FIGURE 20 COST PER HUMAN GENOME, 2001-2021
      • 5.2.1.3 Use of NGS as substitute for PCR
      • 5.2.1.4 Greater efficiency of genotyping and preparation protocols
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Presence of alternative technologies
      • 5.2.2.2 Limited expertise and sequencing capabilities of individual laboratories
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing collaborations and partnerships among key players
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Ethical and privacy issues in health data
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 SUPPLY AND VALUE CHAIN ANALYSIS
    • 5.5.1 SUPPLY CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
    • FIGURE 22 NGS SAMPLE PREPARATION MARKET: SUPPLY CHAIN ANALYSIS
    • 5.5.2 VALUE CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
    • FIGURE 23 NGS SAMPLE PREPARATION MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 24 NGS SAMPLE PREPARATION MARKET: ECOSYSTEM ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 NGS SAMPLE PREPARATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 FDA APPROVALS
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PRICING ANALYSIS
    • TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
    • 5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.10 PATENT ANALYSIS
    • FIGURE 25 PATENT FILING TRENDS FOR TOP 5 IPC MAIN CLASSES, 2018-2020
  • 5.11 KEY CONFERENCES AND EVENTS IN 2023
    • 5.11.1 CONFERENCES ON NGS SAMPLE PREPARATION IN 2023
    • TABLE 11 CONFERENCES ON NGS SAMPLE PREPARATION (2023)
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN NGS SAMPLE PREPARATION MARKET
    • 5.12.2 BUYING CRITERIA FOR NGS SAMPLE PREPARATION MARKET
    • FIGURE 27 KEY BUYING CRITERIA FOR END USERS

6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 12 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 WORKSTATIONS/INSTRUMENTS
    • 6.2.1 INCREASING DEMAND FOR AUTOMATION OF NGS TO PROPEL MARKET
    • TABLE 13 NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 14 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 15 EUROPE: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 REAGENTS & CONSUMABLES
    • 6.3.1 GROWING USE OF CONSUMABLES FOR NGS SAMPLE PREPARATION TO DRIVE MARKET
    • TABLE 18 NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET
    • TABLE 23 NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 24 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 EUROPE: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW

  • 7.1 INTRODUCTION
    • TABLE 28 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • 7.2 DNA FRAGMENTATION & LIBRARY PREPARATION
    • 7.2.1 AVAILABILITY OF PRODUCTS FROM VARIOUS PLAYERS TO DRIVE MARKET
    • TABLE 29 NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 30 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 TARGET ENRICHMENT
    • 7.3.1 LAUNCH OF ADVANCED TARGET ENRICHMENT SOLUTIONS AND TECHNOLOGIES TO DRIVE MARKET
    • TABLE 34 NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 EUROPE: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 QUALITY CONTROL
    • 7.4.1 RISING NUMBER OF RESEARCH ACTIVITIES REQUIRING QUALITY-ASSURED SAMPLES TO PROPEL MARKET
    • TABLE 39 NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 EUROPE: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021-2028 (USD MILLION)

8 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE

  • 8.1 INTRODUCTION
    • TABLE 44 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
  • 8.2 DNA
    • 8.2.1 RISING NUMBER OF CANCER CASES AND GROWING R&D INVESTMENTS FOR STUDYING DNA SAMPLES TO DRIVE MARKET
    • TABLE 45 NGS SAMPLE PREPARATION MARKET FOR DNA, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 RNA
    • 8.3.1 DECREASED COSTS OF GENOME SEQUENCING TO AUGMENT MARKET
    • TABLE 50 NGS SAMPLE PREPARATION MARKET FOR RNA, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 EUROPE: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021-2028 (USD MILLION)

9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 55 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 DISEASE DIAGNOSTICS
    • TABLE 56 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 58 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.1 CANCER DIAGNOSTICS
      • 9.2.1.1 Increase in cancer patients globally and launch of NGS-based cancer panels to drive market
    • TABLE 62 CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.2 REPRODUCTIVE HEALTH DIAGNOSTICS
      • 9.2.2.1 Increasing awareness about benefits of NIPT and decreasing costs of sequencing to propel market
    • TABLE 67 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 68 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.3 INFECTIOUS DISEASE DIAGNOSTICS
      • 9.2.3.1 Growing burden of healthcare-associated infections to aid market
    • TABLE 72 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS
    • TABLE 77 OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 LATIN AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 DRUG DISCOVERY
    • 9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS TO AUGMENT MARKET
    • TABLE 82 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 AGRICULTURAL & ANIMAL RESEARCH
    • 9.4.1 INCREASED FUNDING AND SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO FUEL ADOPTION
    • TABLE 87 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 OTHER APPLICATIONS
    • TABLE 92 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

10 NGS SAMPLE PREPARATION MARKET, BY METHOD

  • 10.1 INTRODUCTION
    • TABLE 97 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 10.2 MANUAL SAMPLE PREPARATION
    • 10.2.1 ERRORS ASSOCIATED WITH NGS MANUAL SAMPLE PREPARATION TO HINDER MARKET
    • TABLE 98 NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 MICROFLUIDIC SAMPLE PREPARATION
    • 10.3.1 GROWING APPLICATIONS OF MICROFLUIDIC SAMPLE PREPARATION TO CREATE OPPORTUNITIES
    • TABLE 103 NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION
    • 10.4.1 HIGH PERFORMANCE AND ACCURACY OF AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION TO BOOST GROWTH
    • TABLE 108 NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 109 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)

11 NGS SAMPLE PREPARATION MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 113 NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2 HOSPITALS & CLINICS
    • 11.2.1 ADVANTAGES OF NGS TECHNOLOGY FOR DISEASE DIAGNOSIS OVER CONVENTIONAL METHOD TO FUEL ADOPTION
    • TABLE 114 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 118 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3 ACADEMIC INSTITUTES & RESEARCH CENTERS
    • 11.3.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT SEGMENT
    • TABLE 119 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 120 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 EUROPE: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 123 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.4.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE GROWTH
    • TABLE 124 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 125 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.5 OTHER END USERS
    • TABLE 129 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 130 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 133 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

12 NGS SAMPLE PREPARATION MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 28 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021 VS. 2028 (USD MILLION)
    • TABLE 134 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT
    • TABLE 135 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 136 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 137 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 138 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028
    • TABLE 139 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028
    • TABLE 140 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028
    • TABLE 141 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028
    • TABLE 142 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028
    • 12.2.1 US
      • 12.2.1.1 Favorable regulatory and reimbursement scenarios to drive market
    • TABLE 143 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 144 US: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 145 US: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 US: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 147 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 148 US: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 US: NGS SAMPLE PREPARATION MARKET BY END USER, 2021-2028 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Favorable government funding to boost genomics research
    • TABLE 150 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 151 CANADA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 152 CANADA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 CANADA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 154 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 155 CANADA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 CANADA: NGS SAMPLE PREPARATION MARKET, FOR END USER, 2021-2028 (USD MILLION)
    • 12.2.3 NORTH AMERICA: IMPACT OF RECESSION
  • 12.3 EUROPE
    • TABLE 157 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 158 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 159 EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 160 EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 162 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 163 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 164 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Strong R&D base and presence of several NGS players to support market
    • TABLE 165 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 166 GERMANY: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 167 GERMANY: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 GERMANY: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 169 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 170 GERMANY: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Use of NGS-based tests for disease diagnosis to augment market
    • TABLE 172 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 173 UK: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 174 UK NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 175 UK NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 176 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 177 UK: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 178 UK: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Growing government support for genomics research to propel market
    • TABLE 179 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 180 FRANCE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 181 FRANCE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 FRANCE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 183 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 184 FRANCE: NGS SAMPLE PREPARATION MARKET BY DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 185 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.4 REST OF EUROPE
    • TABLE 186 REST OF EUROPE NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 187 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
    • TABLE 188 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.5 EUROPE: IMPACT OF RECESSION
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Favorable government initiatives for advanced life science research to aid market
    • 12.4.2 JAPAN
      • 12.4.2.1 Increased research funding to create growth opportunities for NGSbased studies
    • 12.4.3 INDIA
      • 12.4.3.1 Decreasing sequencing costs and growing prevalence of target diseases to support market
    • 12.4.4 AUSTRALIA
      • 12.4.4.1 Increasing use of NGS platforms by academic institutes to propel market
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Increasing spending by government on NGS research to augment market
    • 12.4.6 REST OF ASIA PACIFIC
    • 12.4.7 ASIA PACIFIC: IMPACT OF RECESSION
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Rising focus on clinical genomics to drive demand for NGS
    • 12.5.2 MEXICO
      • 12.5.2.1 Growing biotechnology infrastructure development to support market
    • 12.5.3 REST OF LATIN AMERICA
    • 12.5.4 LATIN AMERICA: IMPACT OF RECESSION
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 INTRODUCTION OF COST-EFFECTIVE AND PORTABLE NGS TECHNOLOGIES TO STIMULATE MARKET

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS
  • 13.3 REVENUE SHARE ANALYSIS (TOP 5 PLAYERS)
  • 13.4 MARKET SHARE ANALYSIS (2022)
  • 13.5 COMPANY EVALUATION QUADRANT
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
  • 13.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 STARTING BLOCKS
    • 13.6.3 RESPONSIVE COMPANIES
    • 13.6.4 DYNAMIC COMPANIES
  • 13.7 COMPETITIVE BENCHMARKING
    • 13.7.1 DETAILED LIST OF START-UPS/SMES
    • 13.7.2 COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES)
  • 13.8 COMPETITIVE SCENARIO AND TRENDS
    • 13.8.1 KEY DEALS
    • 13.8.2 KEY PRODUCT LAUNCHES
    • 13.8.3 KEY EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 ILLUMINA, INC.
    • 14.1.2 THERMO FISHER SCIENTIFIC INC.
    • 14.1.3 F. HOFFMANN-LA ROCHE LTD.
    • 14.1.4 PERKINELMER INC.
    • 14.1.5 AGILENT TECHNOLOGIES, INC.
    • 14.1.6 DANAHER
    • 14.1.7 BECTON, DICKINSON AND COMPANY
    • 14.1.8 QIAGEN
    • 14.1.9 MERCK KGAA
    • 14.1.10 BIO-RAD LABORATORIES, INC.
    • 14.1.11 PROMEGA CORPORATION
    • 14.1.12 EUROFINS SCIENTIFIC
    • 14.1.13 BGI
    • 14.1.14 10X GENOMICS
    • 14.1.15 SYSMEX CORPORATION
  • 14.2 OTHER PLAYERS
    • 14.2.1 PSOMAGEN
    • 14.2.2 ZYMO RESEARCH CORPORATION
    • 14.2.3 TAKARA BIO INC.
    • 14.2.4 NOVOGENE CO., LTD.
    • 14.2.5 NEW ENGLAND BIOLABS
    • 14.2.6 TECAN TRADING AG
    • 14.2.7 OXFORD NANOPORE TECHNOLOGIES PLC
    • 14.2.8 PACBIO
    • 14.2.9 MEDGENOME
    • 14.2.10 SWIFT BIOSCIENCES INC.

15 DISCUSSION GUIDE

  • 15.1 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
  • 15.2 CUSTOMIZATION OPTIONS
  • 15.3 RELATED REPORTS
  • 15.4 AUTHOR DETAILS